Gene Therapy in Cardiovascular Disorder - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2754354
- Published On: Oct, 2023
- Category : Healthcare & Pharma
- Pages : 135
-
According to Research, the global market for Gene Therapy in Cardiovascular Disorder should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Gene Therapy in Cardiovascular Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Gene Therapy in Cardiovascular Disorder market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Heart Disease grew percent to account for percent of the total market sales, and Vascular Disease grew percent.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report studies and analyses global Gene Therapy in Cardiovascular Disorder status and future trends, to help determine the Gene Therapy in Cardiovascular Disorder market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Gene Therapy in Cardiovascular Disorder, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Gene Therapy in Cardiovascular Disorder market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Gene Therapy in Cardiovascular Disorder by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Gene Therapy in Cardiovascular Disorder by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Gene Therapy in Cardiovascular Disorder key consuming regions, consumption value and demand structure
(5) Gene Therapy in Cardiovascular Disorder industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Renovacor
Gene Biotherapeutics
AskBio
Human Stem Cells Institute
Novartis
Market segment by Type, covers
Viral Gene Therapy
Non-viral Gene Therapy
Market segment by Application, can be divided into
Heart Disease
Vascular Disease
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Gene Therapy in Cardiovascular Disorder product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Gene Therapy in Cardiovascular Disorder market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Gene Therapy in Cardiovascular Disorder market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Gene Therapy in Cardiovascular Disorder industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Gene Therapy in Cardiovascular Disorder Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Gene Therapy in Cardiovascular Disorder Definition
1.2 Global Gene Therapy in Cardiovascular Disorder Market Size and Forecast
1.3 China Gene Therapy in Cardiovascular Disorder Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Gene Therapy in Cardiovascular Disorder Market Size: China VS Global Growth Rate, 2018-2029
1.6 Gene Therapy in Cardiovascular Disorder Market Dynamics
1.6.1 Gene Therapy in Cardiovascular Disorder Market Drivers
1.6.2 Gene Therapy in Cardiovascular Disorder Market Restraints
1.6.3 Gene Therapy in Cardiovascular Disorder Industry Trends
1.6.4 Gene Therapy in Cardiovascular Disorder Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Gene Therapy in Cardiovascular Disorder, Global Market Share by Company, 2018-2023
2.2 Global Gene Therapy in Cardiovascular Disorder Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Gene Therapy in Cardiovascular Disorder Concentration Ratio
2.4 Global Gene Therapy in Cardiovascular Disorder Mergers & Acquisitions, Expansion Plans
2.5 Global Gene Therapy in Cardiovascular Disorder Major Companies Product Type
2.6 Head Office and Gene Therapy in Cardiovascular Disorder Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Gene Therapy in Cardiovascular Disorder, China Market Share by Company, 2018-2023
3.2 China Gene Therapy in Cardiovascular Disorder Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Gene Therapy in Cardiovascular Disorder Industry Chain
4.2 Gene Therapy in Cardiovascular Disorder Upstream Analysis
4.2.1 Gene Therapy in Cardiovascular Disorder Core Raw Materials
4.2.2 Main Manufacturers of Gene Therapy in Cardiovascular Disorder Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Gene Therapy in Cardiovascular Disorder Production Mode
4.6 Gene Therapy in Cardiovascular Disorder Procurement Model
4.7 Gene Therapy in Cardiovascular Disorder Industry Sales Model and Sales Channels
4.7.1 Gene Therapy in Cardiovascular Disorder Sales Model
4.7.2 Gene Therapy in Cardiovascular Disorder Typical Distributors
5 Sights by Type5.1 Gene Therapy in Cardiovascular Disorder Classification
5.1.1 Viral Gene Therapy
5.1.2 Non-viral Gene Therapy5.2 By Type, Global Gene Therapy in Cardiovascular Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Gene Therapy in Cardiovascular Disorder Consumption Value, 2018-2029
6 Sights by Application6.1 Gene Therapy in Cardiovascular Disorder Segment by Application
6.1.1 Heart Disease
6.1.2 Vascular Disease6.2 By Application, Global Gene Therapy in Cardiovascular Disorder Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Gene Therapy in Cardiovascular Disorder Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Gene Therapy in Cardiovascular Disorder Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Gene Therapy in Cardiovascular Disorder Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Gene Therapy in Cardiovascular Disorder & Forecasts, 2018-2029
7.3.2 By Country, North America Gene Therapy in Cardiovascular Disorder Market Size Market Share7.4 Europe
7.4.1 Europe Gene Therapy in Cardiovascular Disorder Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Gene Therapy in Cardiovascular Disorder Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Gene Therapy in Cardiovascular Disorder Market Size Market Share7.6 South America
7.6.1 South America Gene Therapy in Cardiovascular Disorder Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Gene Therapy in Cardiovascular Disorder Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Gene Therapy in Cardiovascular Disorder Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Gene Therapy in Cardiovascular Disorder Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.3.2 By Type, U.S. Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.4.2 By Type, Europe Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.5.2 By Type, China Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.6.2 By Type, Japan Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.7.2 By Type, South Korea Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.9.2 By Type, India Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Gene Therapy in Cardiovascular Disorder Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Renovacor
9.1.1 Renovacor Company Information, Head Office, Market Area and Industry Position
9.1.2 Renovacor Company Profile and Main Business
9.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Models, Specifications and Application
9.1.4 Renovacor Gene Therapy in Cardiovascular Disorder Revenue and Gross Margin, 2018-2023
9.1.5 Renovacor Recent Developments9.2 Gene Biotherapeutics
9.2.1 Gene Biotherapeutics Company Information, Head Office, Market Area and Industry Position
9.2.2 Gene Biotherapeutics Company Profile and Main Business
9.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Models, Specifications and Application
9.2.4 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue and Gross Margin, 2018-2023
9.2.5 Gene Biotherapeutics Recent Developments9.3 AskBio
9.3.1 AskBio Company Information, Head Office, Market Area and Industry Position
9.3.2 AskBio Company Profile and Main Business
9.3.3 AskBio Gene Therapy in Cardiovascular Disorder Models, Specifications and Application
9.3.4 AskBio Gene Therapy in Cardiovascular Disorder Revenue and Gross Margin, 2018-2023
9.3.5 AskBio Recent Developments9.4 Human Stem Cells Institute
9.4.1 Human Stem Cells Institute Company Information, Head Office, Market Area and Industry Position
9.4.2 Human Stem Cells Institute Company Profile and Main Business
9.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Models, Specifications and Application
9.4.4 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue and Gross Margin, 2018-2023
9.4.5 Human Stem Cells Institute Recent Developments9.5 Novartis
9.5.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.5.2 Novartis Company Profile and Main Business
9.5.3 Novartis Gene Therapy in Cardiovascular Disorder Models, Specifications and Application
9.5.4 Novartis Gene Therapy in Cardiovascular Disorder Revenue and Gross Margin, 2018-2023
9.5.5 Novartis Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Gene Therapy in Cardiovascular Disorder Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Gene Therapy in Cardiovascular Disorder Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
It is expected that the Gene Therapy in Cardiovascular Disorder Global and China Top Players Market will reach USD XX million by 2029.
According to the Gene Therapy in Cardiovascular Disorder Global and China Top Players Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
The Gene Therapy in Cardiovascular Disorder Global and China Top Players Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.
